[Form 4] Fathom Holdings Inc. Insider Trading Activity
Marco Fregenal, Chief Executive Officer and Director of Fathom Holdings Inc. (FTHM), reported insider transactions dated 08/20/2025. The filing shows a disposition of 1,619,353 shares of common stock and continued indirect holdings of 5,056 shares (held by spouse) and 15,000 shares (held in the Fregenal 2020 Irrevocable Trust). The report also records issuance/acquisition of performance rights: 200,000 performance rights granted on 08/20/2025 (underlying 200,000 shares, $0 exercise price, exercisable by 08/20/2028) and 50,000 performance rights exercisable 11/15/2034. Certain restricted shares and vesting schedules are disclosed and the form is signed by power of attorney on 08/21/2025.
- Grant of 200,000 performance rights with $0 exercise price that convert into common stock if specified price targets are met, aligning long‑term management incentives
- Additional 50,000 performance rights exercisable in 2034 providing further long‑dated incentive alignment
- Clear disclosure of indirect holdings and vesting schedules, including trust holdings and restricted share vesting dates
- Disposition of 1,619,353 common shares by the CEO/Director on 08/20/2025, a large sale that materially reduces direct common stock holdings
- Significant portion of remaining share exposure is indirect (5,056 shares held by spouse and 15,000 in a trust) rather than direct ownership
Insights
TL;DR: Large share disposition coincides with new long‑dated performance rights, producing a mixed signal on insider alignment.
The sale of 1,619,353 common shares is a material share disposition by the CEO and Director and may affect perceived insider alignment in the near term because it reduces direct common stock ownership. Offsetting this, the grant of 200,000 performance rights (zero exercise price, tied to share‑price performance) and an additional 50,000 performance rights provide long‑dated equity upside for management and retain potential alignment with shareholders if performance targets are met. The filing discloses indirect holdings (5,056 and 15,000 shares) and restricted share vesting dates which clarify remaining insider exposure. Overall, the combined package implies near‑term liquidity or rebalancing together with retained long‑term incentive exposure.
TL;DR: Governance view: a significant sale by a top executive paired with performance‑based awards; documentation and vesting schedules are clearly disclosed.
The Form 4 provides transparent disclosure of the CEO/Director relationship to the issuer and details of indirect ownership and trusts, including a disclaimer of beneficial ownership for trust‑held shares. Vesting schedules for restricted shares and the structure of performance rights (contingent on share price for specified durations) are explicitly stated, supporting clear governance reporting. The use of a power of attorney for signature is noted. From a governance perspective, the filing meets Section 16 reporting requirements and supplies meaningful detail about incentive alignment and delegation of execution.